医学部・先端ロボット・内視鏡手術学

Medicine and Dentistry

1. Neoplasm 100%
2. Rectum Cancer 96%
3. Gastrectomy 86%
4. Recurrent Disease 63%
5. Stomach Cancer 57%
6. Surgery 45%
7. Gastrointestinal Stromal Tumor 42%
8. Laparoscopy 40%
9. Cancer Surgery 38%
10. Lymph Node Metastasis 36%
11. Clinician 36%
12. Abdominal Cancer 36%
13. Retrospective Study 36%
14. Surgeon 35%
15. Metastatic Carcinoma 34%
16. Chemoradiotherapy 30%
17. Adjuvant Chemotherapy 28%
18. Bleeding 27%
19. Da Vinci Surgical System 26%
20. Lymph Node 26%
21. Distal Pancreatectomy 24%
22. Liver Metastasis 24%
23. Conversion Therapy 24%
24. Imatinib 24%
25. Constipation 24%
26. Defecation Habit 24%
27. Colorectal Carcinoma 24%
28. Laparoscopic Surgery 23%
29. Retroperitoneal Lymph Node Dissection 23%
30. Surgical Margin 22%
31. Robot-Assisted Surgery 22%
32. Postoperative Complication 20%
33. Malignant Neoplasm 20%
34. Diarrhea 18%
35. Radiation Therapy 18%
36. Hepatectomy 18%
37. Fistula 18%
38. Biopsy 18%
39. Colon 16%
40. Surgical Technique 16%
41. Colectomy 16%
42. Colon Cancer 16%
43. Feces Incontinence 16%
44. Neoadjuvant Therapy 15%
45. Hazard Ratio 15%
46. Prospective Study 14%
47. Paraaortic Lymph Node 14%
48. Sigmoid Cancer 14%
49. Sigmoidectomy 14%
50. Carcinoma 13%
51. Pelvis 13%
52. Clinical Feature 13%
53. Cohort Analysis 13%
54. Colorectal Cancer 13%
55. Anus 13%
56. Esophagectomy 12%
57. Esophageal Cancer 12%
58. Disease 12%
59. Incision 12%
60. Esophagus 12%
61. Crohn's Disease 12%
62. Ulcerative Colitis 12%
63. Cancer 12%
64. Intestine Cancer 12%
65. Endoscopic Surgery 12%
66. Squamous Cell Carcinoma 12%
67. FOLFIRI 12%
68. Chylothorax 12%
69. Leiomyosarcoma 12%
70. Monotherapy 12%
71. Perianal Abscess 12%
72. Pancreas Cancer 12%
73. Daikenchuto 12%
74. Liver Arteriography 12%
75. Superior Mesenteric Artery 12%
76. Colon Carcinoma 12%
77. Colon Motility 12%
78. Lymphocyte 12%
79. Appendectomy 12%
80. Lymphangiography 12%
81. Stomach Surgery 12%
82. Upper Gastrointestinal Surgery 12%
83. Anal Fistula 12%
84. Multimodality Cancer Therapy 12%
85. Arteriovenous Malformation 12%
86. Granular Cell Tumor 12%
87. Tumor Mutation Burden 12%
88. Nivolumab 12%
89. Interventional Radiology 12%
90. Stenting 12%
91. Kocher Manoeuvre 12%
92. Thorax Surgery 12%
93. Empyema 12%
94. Posterior Colporrhaphy 12%
95. Rectocele 12%
96. Prevalence 12%
97. Comprehensive Genomic Profiling 12%
98. Systemic Therapy 10%
99. Overall Survival 9%
100. Fluorouracil 9%

Keyphrases

1. Tumor 42%
2. Colorectal Cancer 37%
3. Anal Squamous Cell Carcinoma 24%
4. Gastric Cancer 24%
5. Chemotherapy 19%
6. Adjuvant Chemotherapy 18%
7. Stomach 18%
8. Robotic Distal Gastrectomy 18%
9. Colon 14%
10. R0 Resection 14%
11. Clinical Features 13%
12. Curative Surgery 13%
13. High Risk 13%
14. Rectum 13%
15. Treatment Outcome 12%
16. Leonardo Da Vinci 12%
17. Intestinal Cancer 12%
18. Crohn's Disease 12%
19. Resection 12%
20. Stable Disease 12%
21. Japanese Population 12%
22. Surgical Technique 12%
23. FOLFIRI 12%
24. FOLFIRINOX 12%
25. Chemoradiotherapy 12%
26. Expert Survey 12%
27. Leiomyosarcoma 12%
28. Hinotori 12%
29. Cisplatin Delivery 12%
30. Neoadjuvant Therapy 12%
31. Skip Metastasis 12%
32. Lateral Lymph Node Metastasis 12%
33. Carcinoma Associated with Anal Fistula 12%
34. Cancer-related 12%
35. Molecular Pathways 12%
36. Laparoscopic Distal Pancreatectomy 12%
37. Conversion Surgery 12%
38. Gastrointestinal Stromal Tumor 12%
39. Mutation Analysis 12%
40. Ulcerative Colitis 12%
41. CT during Hepatic Arteriography 12%
42. After Surgery 12%
43. Laparoscopy-assisted Gastrectomy 12%
44. Duodenal Gastrointestinal Stromal Tumors 12%
45. Rectal Carcinoma 12%
46. Neoadjuvant Chemoradiotherapy (nCRT) 12%
47. Superior Mesenteric Artery 12%
48. Esophageal Stenting 12%
49. Esophagorespiratory Fistula 12%
50. Conversion Therapy 12%
51. Colorectal Cancer Patients 12%
52. Resectable Pancreatic Cancer 12%
53. Curative Resection 12%
54. Minimally Invasive Distal Pancreatectomy 12%
55. S-system 12%
56. Local Gastrectomy 12%
57. Endoscopic Surgical Skill Qualification System 12%
58. Gastric Bypass Surgery 12%
59. Robot-assisted Surgery 12%
60. Low Rectal Cancer 12%
61. Median Arcuate Ligament 12%
62. Near-infrared Photoimmunotherapy (NIR-PIT) 12%
63. Lung 12%
64. Retrospective Analysis 12%
65. Postoperative Follow-up 12%
66. Colon Cancer Patients 12%
67. Histological Remission 12%
68. Lymph Node Metastasis 12%
69. Single-incision Laparoscopy 12%
70. Umbilical Port 12%
71. Oncological Outcomes 12%
72. Margin Quality 12%
73. Radiation Therapy 12%
74. Rehepatectomy 12%
75. Surgical Systems 12%
76. Pelvic Arteriovenous Malformation 12%
77. Gastric Cancer with Liver Metastasis 12%
78. TME Quality 12%
79. Para-aortic Lymph Node Metastasis 12%
80. Tumor mutation Burden 12%
81. Multidisciplinary Therapy 12%
82. Da Vinci Surgical System 12%
83. Kocher Maneuver 12%
84. Medical Personnel 12%
85. Female-to-male 12%
86. Bowel Habits 12%
87. Questionnaire Survey 12%
88. Robotic Gastrectomy 12%
89. Da Vinci Xi System 12%
90. Clinical Experience 12%
91. Single-center Retrospective Study 12%
92. CRP to Albumin Ratio 10%
93. Hazard Ratio 10%
94. Confidence Interval 10%
95. Postoperative Course 10%
96. Older Men 10%
97. Perianal Lesion 9%
98. Lipiodol Lymphangiography 8%
99. X-ray Study 8%
100. Liver Surface 8%